{"id":"https://openalex.org/W7204851908","doi":"https://doi.org/10.7188/bvsz.2025.101.5.7","title":"Allogeneic hematopoietic stem cell transplantation in cutaneous T-cell lymphoma \u2013 A rarely applied but potentially curative therapeutic option","display_name":"Allogeneic hematopoietic stem cell transplantation in cutaneous T-cell lymphoma \u2013 A rarely applied but potentially curative therapeutic option","alternate_titles":["Allog\u00e9n \u0151ssejt-transzplant\u00e1ci\u00f3 cutan T-sejtes lymphom\u00e1ban \u2013 Egy ritka, de potenci\u00e1lisan kurat\u00edv lehet\u0151s\u00e9g"],"publication_year":2025,"publication_date":"2025-10-17","ids":{"openalex":"https://openalex.org/W7204851908","doi":"https://doi.org/10.7188/bvsz.2025.101.5.7"},"language":"en","primary_location":{"id":"doi:10.7188/bvsz.2025.101.5.7","doi":"https://doi.org/10.7188/bvsz.2025.101.5.7","is_oa":true,"landing_page_url":"https://doi.org/10.7188/bvsz.2025.101.5.7","pdf_url":"https://doi.org/10.7188/bvsz.2025.101.5.7","source":{"id":"https://openalex.org/S4210206206","display_name":"B\u0151rgy\u00f3gy\u00e1szati \u00e9s Venerol\u00f3giai Szemle","issn_l":"0006-7768","issn":["0006-7768","2064-261X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"B\u0151rgy\u00f3gy\u00e1szati \u00e9s Venerol\u00f3giai Szemle","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7204851908"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.7188/bvsz.2025.101.5.7","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037532870","display_name":"Alexandra Raska","orcid":"https://orcid.org/0000-0002-5348-2264","observed_orcids":["https://orcid.org/0000-0002-5348-2264"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandra Raska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041765633","display_name":"L\u00e1szl\u00f3 Gopcsa","orcid":"https://orcid.org/0000-0003-4930-7049","observed_orcids":["https://orcid.org/0000-0003-4930-7049"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L\u00e1szl\u00f3 Gopcsa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082857027","display_name":"Hajnalka Andrikovics","orcid":"https://orcid.org/0000-0002-8368-9784","observed_orcids":["https://orcid.org/0000-0002-8368-9784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hajnalka Andrikovics","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148818504","display_name":"Alexandra Balogh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandra Balogh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148802823","display_name":"J\u00e1nos F\u00e1bi\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J\u00e1nos F\u00e1bi\u00e1n","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108762517","display_name":"P\u00e9ter Farkas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P\u00e9ter Farkas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119099080","display_name":"Krisztina Jeszenszky","orcid":"https://orcid.org/0009-0008-1123-065X","observed_orcids":["https://orcid.org/0009-0008-1123-065X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Krisztina Jeszenszky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051996152","display_name":"Viktor Lakatos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Viktor Lakatos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148813417","display_name":"Tam\u00e1s Masszi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tam\u00e1s Masszi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066175900","display_name":"N\u00f3ra Meggyesi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N\u00f3ra Meggyesi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046329848","display_name":"Melinda Paksi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melinda Paksi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148806540","display_name":"B\u00e1lint Szab\u00f3","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B\u00e1lint Szab\u00f3","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049676578","display_name":"Anik\u00f3 Szilv\u00e1si","orcid":"https://orcid.org/0000-0002-4092-6073","observed_orcids":["https://orcid.org/0000-0002-4092-6073"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anik\u00f3 Szilv\u00e1si","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079405407","display_name":"Ilona T\u00e1rk\u00e1nyi","orcid":"https://orcid.org/0000-0002-4373-3947","observed_orcids":["https://orcid.org/0000-0002-4373-3947"]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]},{"id":"https://openalex.org/I4210097504","display_name":"Hungarian National Blood Transfusion Service","ror":"https://ror.org/00qtxnd58","country_code":"HU","type":"other","lineage":["https://openalex.org/I4210097504"]},{"id":"https://openalex.org/I4210155792","display_name":"Jahn Ferenc D\u00e9l-Pesti K\u00f3rh\u00e1z \u00e9s Rendel\u0151int\u00e9zet","ror":"https://ror.org/05fx84t54","country_code":"HU","type":"healthcare","lineage":["https://openalex.org/I4210155792"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Ilona T\u00e1rk\u00e1nyi","raw_affiliation_strings":["Semmelweis Egyetem Belgy\u00f3gy\u00e1szati \u00e9s Hematol\u00f3giai Klinika , Budapest , Orsz\u00e1gos V\u00e9rell\u00e1t\u00f3 Szolg\u00e1lat , Budapest","\u0150ssejttranszplant\u00e1ci\u00f3s Oszt\u00e1ly , Budapest , D\u00e9l-pesti Centrumk\u00f3rh\u00e1z -Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Semmelweis Egyetem Belgy\u00f3gy\u00e1szati \u00e9s Hematol\u00f3giai Klinika , Budapest , Orsz\u00e1gos V\u00e9rell\u00e1t\u00f3 Szolg\u00e1lat , Budapest","institution_ids":["https://openalex.org/I101202996","https://openalex.org/I4210097504"]},{"raw_affiliation_string":"\u0150ssejttranszplant\u00e1ci\u00f3s Oszt\u00e1ly , Budapest , D\u00e9l-pesti Centrumk\u00f3rh\u00e1z -Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet ,","institution_ids":["https://openalex.org/I4210155792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075279096","display_name":"Nikolett Wohner","orcid":"https://orcid.org/0000-0003-3762-0388","observed_orcids":["https://orcid.org/0000-0003-3762-0388"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikolett Wohner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5148775928","display_name":"P\u00e9ter Rem\u00e9nyi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P\u00e9ter Rem\u00e9nyi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"101","issue":"5","first_page":"268","last_page":"275"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma","display_name":"cutaneous T-cell lymphoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":1.0},{"id":"https://openalex.org/keywords/reduced-intensity-conditioning","display_name":"reduced-intensity conditioning","score":0.7649999856948853},{"id":"https://openalex.org/keywords/myeloablative-conditioning","display_name":"myeloablative conditioning","score":0.9980000257492065},{"id":"https://openalex.org/keywords/acute-graft-versus-host-disease","display_name":"acute graft-versus-host disease","score":0.8740000128746033},{"id":"https://openalex.org/keywords/donor-lymphocyte-infusion","display_name":"donor lymphocyte infusion","score":0.9580000042915344},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7319999933242798},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5400000214576721},{"id":"https://openalex.org/keywords/advanced-disease","display_name":"advanced disease","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8794000148773193},{"id":"https://openalex.org/C3020284061","wikidata":"https://www.wikidata.org/wiki/Q5194613","display_name":"Curative treatment","level":3,"score":0.6026999950408936},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5742999911308289},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5526999831199646},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.5476999878883362},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.5453000068664551},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5113000273704529},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5109000205993652},{"id":"https://openalex.org/C2779695342","wikidata":"https://www.wikidata.org/wiki/Q5296800","display_name":"Donor lymphocyte infusion","level":4,"score":0.5080000162124634},{"id":"https://openalex.org/C3018657049","wikidata":"https://www.wikidata.org/wiki/Q1595418","display_name":"Complete remission","level":3,"score":0.4555000066757202},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.43700000643730164},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4230000078678131},{"id":"https://openalex.org/C2776780870","wikidata":"https://www.wikidata.org/wiki/Q5196687","display_name":"Cutaneous T-cell lymphoma","level":4,"score":0.40369999408721924},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.36469998955726624},{"id":"https://openalex.org/C2779972918","wikidata":"https://www.wikidata.org/wiki/Q1194520","display_name":"Graft-versus-host disease","level":3,"score":0.35760000348091125},{"id":"https://openalex.org/C2777756187","wikidata":"https://www.wikidata.org/wiki/Q1891209","display_name":"Mycosis fungoides","level":3,"score":0.3506999909877777},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.3425000011920929},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.3357999920845032},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3084999918937683},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2964000105857849},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2879999876022339},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.28610000014305115},{"id":"https://openalex.org/C2993713153","wikidata":"https://www.wikidata.org/wiki/Q211709","display_name":"Hematopoietic cell","level":4,"score":0.28290000557899475},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.2766000032424927},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.272599995136261},{"id":"https://openalex.org/C2777891184","wikidata":"https://www.wikidata.org/wiki/Q7168693","display_name":"Peripheral T-cell lymphoma","level":4,"score":0.2694999873638153}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.7188/bvsz.2025.101.5.7","doi":"https://doi.org/10.7188/bvsz.2025.101.5.7","is_oa":true,"landing_page_url":"https://doi.org/10.7188/bvsz.2025.101.5.7","pdf_url":"https://doi.org/10.7188/bvsz.2025.101.5.7","source":{"id":"https://openalex.org/S4210206206","display_name":"B\u0151rgy\u00f3gy\u00e1szati \u00e9s Venerol\u00f3giai Szemle","issn_l":"0006-7768","issn":["0006-7768","2064-261X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"B\u0151rgy\u00f3gy\u00e1szati \u00e9s Venerol\u00f3giai Szemle","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.7188/bvsz.2025.101.5.7","doi":"https://doi.org/10.7188/bvsz.2025.101.5.7","is_oa":true,"landing_page_url":"https://doi.org/10.7188/bvsz.2025.101.5.7","pdf_url":"https://doi.org/10.7188/bvsz.2025.101.5.7","source":{"id":"https://openalex.org/S4210206206","display_name":"B\u0151rgy\u00f3gy\u00e1szati \u00e9s Venerol\u00f3giai Szemle","issn_l":"0006-7768","issn":["0006-7768","2064-261X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"B\u0151rgy\u00f3gy\u00e1szati \u00e9s Venerol\u00f3giai Szemle","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204851908.pdf","grobid_xml":"https://content.openalex.org/works/W7204851908.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1491993932","https://openalex.org/W1852839769","https://openalex.org/W1982466572","https://openalex.org/W1984122059","https://openalex.org/W2069325266","https://openalex.org/W2104425796","https://openalex.org/W2152130235","https://openalex.org/W2248062583","https://openalex.org/W2909601941","https://openalex.org/W2913413194","https://openalex.org/W3005007087","https://openalex.org/W3104951635","https://openalex.org/W3119854835","https://openalex.org/W4387765013","https://openalex.org/W4392714783"],"related_works":["https://openalex.org/W2789819929","https://openalex.org/W2604732185","https://openalex.org/W1984101796","https://openalex.org/W2960655424","https://openalex.org/W3091096277","https://openalex.org/W2389789540","https://openalex.org/W2244817895","https://openalex.org/W3037055958","https://openalex.org/W4224992219","https://openalex.org/W4408318783"],"abstract_inverted_index":{"The":[0,91],"management":[1,187],"of":[2,21,50,59,82,93,104,108,130,142,161,188],"advanced-stage":[3],"cutaneous":[4],"T-cell":[5],"lymphomas":[6],"(CTCL)":[7],"remains":[8,178],"a":[9,56,102],"major":[10],"clinical":[11,19],"challenge":[12],"due":[13],"to":[14,28],"the":[15,22,48,87,137,149,186],"pronounced":[16],"biological":[17],"and":[18,24,70,125,148],"heterogeneity":[20],"disease":[23,134],"its":[25,176,193],"frequent":[26],"resistance":[27],"therapy.":[29],"Durable":[30,154],"remission":[31,113,155],"can":[32],"be":[33],"achieved":[34,157],"solely":[35],"through":[36],"allogeneic":[37],"hematopoietic":[38],"stem":[39,63],"cell":[40,64],"transplantation":[41,65,96],"(allo-HSCT).":[42],"In":[43],"this":[44],"summary,":[45],"we":[46],"review":[47],"role":[49],"allo-HSCT":[51,170],"in":[52,66,72,97,111,123,128,140,158,174,185],"CTCL,":[53,175],"based":[54],"on":[55],"retrospective":[57],"analysis":[58],"patients":[60,94,190],"who":[61],"underwent":[62,95],"Budapest":[67],"between":[68],"1984":[69],"2024,":[71],"comparison":[73],"with":[74,115,164],"international":[75],"data.":[76],"CTCL":[77],"accounted":[78],"for":[79],"only":[80],"0.5%":[81],"adult":[83],"allo-HSCTs":[84],"performed":[85],"over":[86],"past":[88],"40":[89],"years.":[90],"majority":[92],"advanced":[98],"stage":[99],"disease,":[100],"following":[101],"median":[103],"three":[105],"prior":[106],"lines":[107],"therapy,":[109],"either":[110],"partial":[112],"or":[114],"progressive":[116],"disease.":[117],"Conditioning":[118],"regimens":[119],"were":[120],"reduced-intensity":[121],"(RIC)":[122],"67%":[124,141],"myeloablative":[126],"(MAC)":[127],"33%":[129],"cases.":[131],"Acute":[132],"graft-versus-host":[133],"(GVHD)":[135],"involving":[136],"skin":[138],"occurred":[139],"patients.":[143],"Overall":[144],"mortality":[145],"was":[146,152,156],"67%,":[147],"relapse":[150,163],"rate":[151],"44%.":[153],"some":[159],"cases":[160],"late":[162],"donor":[165],"lymphocyte":[166],"infusion":[167],"(DLI).":[168],"Although":[169],"offers":[171],"curative":[172],"potential":[173],"application":[177],"limited.":[179],"Closer":[180],"cooperation":[181],"among":[182],"disciplines":[183],"involved":[184],"these":[189],"may":[191],"promote":[192],"more":[194],"widespread":[195],"use.":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7204851908","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-09-01T00:00:00"}
